Stocks · Health care · Pharmaceutical Preparations

GALECTIN THERAPEUTICS INC

GALT Clue Score21
United States Fiscal year ends December CIK 0001133416 Results filed 14 Aug 2026

What the insiders did No buying or selling

By person

10 insiders · 0 transactions
6.8×

Joel Lewis holds 6.8 times base salary in stock. $4.27M of shares against $624.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Joel Lewis last reported holding, valued at $5.13, the price Common Stock was last bought or sold at on the open market here, on 14 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Richard E Uihlein
Director
—
—
—
55,046,519
$282.12M
+166.9%
10X Fund, L.P. entity
10% owner
—
—
—
5,614,457
$28.78M
−5.0%
James C Czirr
10% owner
—
—
—
1,045,541
$5.36M
+41.0%
Joel Lewis
President and CEO
—
—
—
832,592
$4.27M
−6.3%
Kary Eldred
Director
—
—
—
65,682
$336.63K
+32.7%
Kevin D Freeman
Director
—
—
—
55,269
$283.26K
+59.0%
Richard A. Zordani Jr.
Director
—
—
—
42,083
$215.68K
+31.2%
Harold H. Shlevin
Director
—
—
—
26,123
$133.89K
−7.1%
Jack W Callicutt
Chief Financial Officer
—
—
—
7,614
$39.02K
0.0%
Khurram Jamil
Chief Medical Officer
—
—
—
0
$0.00
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.